HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Redaelli Selected Research

Serine (L-Serine)

3/2007Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara Redaelli Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 10/2006
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 12/2006
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2021 - 10/2007
3Leukemia
01/2021 - 05/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2021 - 11/2016
2Critical Illness (Critically Ill)
01/2021 - 12/2016
2Lymphoma (Lymphomas)
11/2016 - 02/2014
2Thyroid Neoplasms (Thyroid Cancer)
09/2013 - 05/2005
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2018
1Neuroblastoma
12/2018
1Respiratory Insufficiency (Respiratory Failure)
12/2016
1Ventilator-Induced Lung Injury
02/2014
1Colonic Neoplasms (Colon Cancer)
09/2013
1medullary Thyroid cancer
09/2013
1Schinzel-Giedion syndrome
01/2013
1Aneuploidy (Aneuploid)
01/2011
1Philadelphia Chromosome
05/2008
1Genetic Translocation (Chromosomal Translocation)
10/2007
1Papillary Thyroid Cancer
10/2006

Drug/Important Bio-Agent (IBA)

4Anaplastic Lymphoma KinaseIBA
09/2021 - 10/2007
4Phosphotransferases (Kinase)IBA
01/2021 - 10/2006
3Imatinib Mesylate (Gleevec)FDA Link
10/2015 - 12/2006
3bosutinibIBA
07/2015 - 12/2006
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2012 - 05/2005
2lorlatinibIBA
12/2018 - 11/2016
2CrizotinibIBA
11/2016 - 02/2014
2Tyrosine Kinase InhibitorsIBA
11/2012 - 05/2008
1p80(NPM-ALK) proteinIBA
09/2021
1Drug CombinationsIBA
09/2021
1Protamine KinaseIBA
01/2021
1Tubulin ModulatorsIBA
01/2021
1temsirolimusFDA Link
11/2016
1MTOR InhibitorsIBA
11/2016
1Carbon DioxideIBA
02/2014
1vandetanib (ZD6474)IBA
09/2013
1ponatinibIBA
09/2013
1Codon (Codons)IBA
01/2013
1Proto-Oncogene Proteins c-bcrIBA
11/2012
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2011
1Cyclin B1IBA
01/2011
1Transcription Factors (Transcription Factor)IBA
01/2011
1taxaneIBA
01/2011
1nilotinibFDA Link
05/2008
1Dasatinib (BMS 354825)FDA Link
05/2008
1DNA-Binding Proteins (DNA Binding Protein)IBA
10/2007
1RNA (Ribonucleic Acid)IBA
10/2007
1beta CateninIBA
03/2007
1Tyrosine (L-Tyrosine)FDA Link
03/2007
1Threonine (L-Threonine)FDA Link
03/2007
1Serine (L-Serine)FDA Link
03/2007
1Semaxinib (SU5416)IBA
10/2006

Therapy/Procedure

3Therapeutics
01/2021 - 02/2014
2Extracorporeal Membrane Oxygenation
01/2021 - 12/2016
1Deep Sedation
01/2021
1Critical Care (Surgical Intensive Care)
12/2016
1Drug Therapy (Chemotherapy)
02/2014